feed,title,long_url,short_url
BioRxiv,AI-Driven and 3D-Bioprinted New Approach Methodology (NAM) Identifies NEO100 as Potent Ultrasound-Activated Therapeutic for Primary and Metastatic Brain Tumors,https://www.biorxiv.org/content/10.1101/2025.11.25.690556v1?rss=1,
